The FDA has cleared Roche’s cobas BV/CV assay, a molecular test that detects bacterial vaginosis and Candida vaginitis from a single swab, enabling streamlined diagnosis on the cobas platform, according to Roche.
A peer-reviewed study suggests molecular signatures can be identified without invasive uterine sampling using whole-transcriptome sequencing and machine learning.
The company will process clinical samples for Path Fertility’s NOA Guide, an epigenetic test designed to inform surgical decision-making for men with non-obstructive azoospermia.
Researchers urge clinicians to integrate lipid management into prenatal care to mitigate elevated obstetric complications and cardiovascular risks.
Read More
Partnership provides mail-in semen analysis as a covered benefit for eligible members.
Read More
The tool uses results from the CA125 blood test along with a woman’s age to generate a personalized risk score for ovarian cancer.
Read More
The new noninvasive prenatal test addresses testing gaps when biological fathers are unavailable for carrier screening by analyzing fetal DNA from maternal blood samples.
Read More
At ADLM 2025, researchers spotlight diagnostic innovations that aim to improve gynecologic cancer detection through greater access and less invasive methods.
Read More
Researchers have developed a highly sensitive, pregnancy-test-like diagnostic device that uses menstrual blood to detect endometriosis early.
Read More
Juniper Genomics has launched publicly to offer a next-generation embryo screening platform that aims to improve IVF outcomes.
Read MoreJoin Tosoh Bioscience and Dr. Giuliana Puccini Santamaria for a deep dive into fertility markers and their role in diagnosing and managing infertility. This webinar explores key indicators like ovarian function, polycystic ovarian syndrome, and the importance of fast, accurate immunoassay results in fertility treatment. Ideal for clinicians seeking actionable insights in reproductive health.
Read More
Innovative IVF techniques are emerging to improve implantation predictions through non-invasive, AI-driven metabolomics assays.
Read More
hc1 has launched HerCare, a new module in its MyBloodHealth platform, to enhance maternal health by providing real-time lab-driven insights.
Read More
A Brazilian study used metabolomic analysis to identify metabolic alterations associated with different severities of preeclampsia.
Read More
The vaginal microbiome is a complex and dynamic ecosystem that varies across populations; research is limited by geographical disparities.
Read More
Yourgene Health has launched IONA Care+, a comprehensive non-invasive prenatal screening service in the UK, expanding its NIPT offerings.
Read More
Roche’s Elecsys sFlt-1/PlGF test received FDA clearance, providing a prognostic way to help ID pregnant women at risk of severe preeclampsia.
Read More
A new study suggests that neuroactive steroid levels in the third trimester may predict postpartum depression risk.
Read More